• OPEN AN ACCOUNT
Indian Indices
Sensex
76,075.09 -316.30
( -0.41%)
Global Indices
Nasdaq
51,722.16 -517.42
(-0.99%)
Dow Jones
7,429.53 -90.43
(-1.20%)
Hang Seng
64,397.99 -2,024.61
(-3.05%)
Nikkei 225
10,630.89 -86.08
(-0.80%)
Forex
USD-INR
96.48 0.17
(0.18%)
EUR-INR
110.06 0.16
(0.15%)
GBP-INR
129.05 -0.06
(-0.05%)
JPY-INR
0.59 0.00
(0.00%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
159.25
468842.05
EPS(TTM)
Face Value()
Div & Yield %
12.27
1
0.82
 

timken india ltd
Shukra Pharmaceuticals reports consolidated net loss of Rs 1.72 crore in the March 2026 quarter
May 08,2026
Net loss of Shukra Pharmaceuticals reported to Rs 1.72 crore in the quarter ended March 2026 as against net profit of Rs 5.39 crore during the previous quarter ended March 2025. Sales declined 52.37% to Rs 6.32 crore in the quarter ended March 2026 as against Rs 13.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 130.27% to Rs 22.06 crore in the year ended March 2026 as against Rs 9.58 crore during the previous year ended March 2025. Sales rose 74.07% to Rs 56.73 crore in the year ended March 2026 as against Rs 32.59 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.3213.27 -52 56.7332.59 74
OPM %11.0855.09 -50.6639.06 -
PBDT1.398.51 -84 32.2316.34 97
PBT0.387.57 -95 28.7913.34 116
NP-1.725.39 PL 22.069.58 130